Dr Thierry Bottai

Dr Thierry Bottai studied at the Faculty of Medicine in Marseille. After receiving a Master’s degree in Neuroscience, he completed his work as university fellow in psychiatry at the university hospital of Montpellier. He is currently Head of Departments of Adult Psychiatry at the Martigues General Hospital (Centre Hospitalier Général de Martigues). He is a lecturer at Aix-Marseille University and has conducted several clinical trials over many years. He is also an expert to the courts. He is a member of several learned societies in France and abroad, the author or numerous articles and more than 150 national and international communications. His research is focused on depression, bipolar disorders, schizophrenic disorders, brief therapies (interpersonal therapies) and psychopharmacology.

Dr Daniel Dassa

Dr Daniel Dassa studied at the Faculty of Medicine in Marseille. After finishing is work as university fellow in psychiatry at the university of Marseille, he completed his Ph.D. on the neurodevelopmental hypothesis of schizophrenia. He then continued his research at the Institute of Psychiatry and at King’s College Hospital in London. He is now Head of department of Adult Psychiatry at Marseille’s University Hospital Center, a lecturer at Aix-Marseille University, and has been an investigator for many years in several clinical trials. He is also an expert to the courts. His research focuses primarily on psychopharmacology. Over the last 20 years, he has published numerous articles and he is a reviewer for various scientific journals such as Schizophrenia Research and Acta Psychiatrica Scandinavica.

Dr Philippe Raymondet

Dr Philippe Raymondet studied at the Faculty of Medicine in Marseilles. After completing his clinical fellow in psychiatry at the university hospital of Marseille, he continued his research at the Royal Victoria Hospital at McGill University in Montreal. He is currently Head of Departments of Adult Psychiatry at Toulon’s University Hospital Center, and lectures at Aix-Marseille University. For many years, he has been an investigator in numerous clinical trials. He is also an expert to the courts. His main areas of interest are psychopharmacology, legal psychiatry and psychosocial rehabilitation for patients with schizophrenia. Over the last 20 years, he has published numerous articles on these subjects.